Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    January 2012
  1. KOTTON CN
    Preventative Tools of the Future: Predicting the Individual Risk of Cytomegalovirus Infection After Transplant.
    Transplantation. 2012.
    PubMed     Text format     Related articles   



    December 2011
  2. LISBOA LF , Kumar D, Wilson LE, Humar A, et al
    Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  3. WITZKE O , Hauser IA, Bartels M, Wolf G, et al
    Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  4. ANDREWS PA , Emery VC, Newstead C
    Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  5. HIEMANN NE , Wellnhofer E, Lehmkuhl HB, Knosalla C, et al
    Everolimus Prevents Endomyocardial Remodeling After Heart Transplantation.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  6. SAITOH A , Sakamoto S, Fukuda A, Shigeta T, et al
    A Universal Preemptive Therapy for Cytomegalovirus Infections in Children After Live-Donor Liver Transplantation.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  7. PARSAIK AK , Bhalla T, Dong M, Rostambeigi N, et al
    Epidemiology of Cytomegalovirus Infection After Pancreas Transplantation.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  8. SHIMAMURA M , Saunders U, Rha B, Guo L, et al
    Ganciclovir Transiently Attenuates Murine Cytomegalovirus-Associated Renal Allograft Inflammation.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. LISBOA LF , Preiksaitis JK, Humar A, Kumar D, et al
    Clinical Utility of Molecular Surveillance for Cytomegalovirus After Antiviral Prophylaxis in High-Risk Solid Organ Transplant Recipients.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. SOLANO C , Benet I, Jose Remigia M, de la Camara R, et al
    Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
    Transplantation. 2011;92:e17-20.
    PubMed     Text format     Related articles   



  11. TRYPHONOPOULOS P , Weppler D, Morris MI, Russo C, et al
    The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center Experience.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  12. MYHRE HA , Haug Dorenberg D, Kristiansen KI, Rollag H, et al
    Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. PLANITZER CB , Saemann MD, Gajek H, Farcet MR, et al
    Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin Preparations.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  14. SINGH N
    Unraveling the Biologic Basis of Late-Onset Cytomegalovirus Disease in High-Risk Organ Transplant Recipients.
    Transplantation. 2011.
    PubMed     Text format     Related articles   



    February 2011
  15. BENMARZOUK-HIDALGO OJ , Cisneros JM, Cordero E, Martin-Pena A, et al
    Therapeutic Effect of the Acquisition of Cytomegalovirus-Specific Immune Response During Preemptive Treatment.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



  16. FUCHINOUE S , Ishii Y, Sawada T, Murakami T, et al
    The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction.
    Transplantation. 2011.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  17. KALIL AC , Florescu DF
    Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines.
    Transplantation. 2011;91:e8-9.
    PubMed     Text format     Related articles   



    December 2010
  18. HUMAR A , Limaye AP, Blumberg EA, Hauser IA, et al
    Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.
    Transplantation. 2010;90:1427-31.
    PubMed     Text format     Related articles    Abstract available



  19. LUAN FL , Kommareddi M, Ojo AO
    Universal Prophylaxis is Cost Effective in Cytomegalovirus Serology-Positive Kidney Transplant Patients.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  20. BOILLAT BLANCO N , Pascual M, Venetz JP, Nseir G, et al
    Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  21. SNYDMAN DR , Kistler KD, Ulsh P, Morris J, et al
    Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  22. WELKER H , Farhan M, Humar A, Washington C, et al
    Ganciclovir Pharmacokinetic Parameters Do Not Change When Extending Valganciclovir Cytomegalovirus Prophylaxis From 100 to 200 Days.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  23. CAMACHO-GONZALEZ AF , Gutman J, Hymes LC, Leong T, et al
    24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  24. BLUMBERG EA , Hauser IA, Stanisic S, Mueller E, et al
    Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  25. LISBOA LF , Asberg A, Kumar D, Pang X, et al
    The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  26. CHOU S , Marousek G, Boivin G, Goyette N, et al
    Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  27. GRIM SA , Pereira E, Guzman G, Clark NM, et al
    CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation.
    Transplantation. 2010;90:799-801.
    PubMed     Text format     Related articles   



    September 2010
  28. KUO HT , Ye X, Sampaio MS, Reddy P, et al
    Cytomegalovirus Serostatus Pairing and Deceased Donor Kidney Transplant Outcomes in Adult Recipients With Antiviral Prophylaxis.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  29. MAGLIONE M , Biebl MO, Bonatti H, Gobel G, et al
    Cytomegalovirus Mismatch as Major Risk Factor for Delayed Graft Function After Pancreas Transplantation.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  30. AVERY RK , Mossad SB, Poggio E, Lard M, et al
    Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  31. ALGHAMDI SA , Nabi ZG, Alkhafaji DM, Askandrani SA, et al
    Transplant tourism outcome: a single center experience.
    Transplantation. 2010;90:184-8.
    PubMed     Text format     Related articles    Abstract available



  32. HANISH SI , Samaniego M, Mezrich JD, Foley DP, et al
    Outcomes of simultaneous liver/kidney transplants are equivalent to kidney transplant alone: a preliminary report.
    Transplantation. 2010;90:52-60.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  33. HEIM C , Abele-Ohl S, Eckl S, Ramsperger-Gleixner M, et al
    Murine Cytomegalovirus Infection Leads to Increased Levels of Transplant Arteriosclerosis in a Murine Aortic Allograft Model.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  34. ZUK DM , Humar A, Weinkauf JG, Lien DC, et al
    An International Survey of Cytomegalovirus Management Practices in Lung Transplantation.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  35. SNYDMAN DR
    Leflunomide: A Small Step Forward in Meeting the Urgent Need for Treatment of Drug-Resistant Cytomegalovirus Infection.
    Transplantation. 2010.
    PubMed     Text format     Related articles   



  36. SINGH N
    Prevention of Cytomegalovirus in Organ Transplant Recipients: Cross Roads Between Antiviral and Antitumor Immunity.
    Transplantation. 2010.
    PubMed     Text format     Related articles   



    May 2010
  37. ROSTAMBEIGI N , Kudva YC, John S, Mailankody S, et al
    Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation.
    Transplantation. 2010;89:1126-33.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  38. NAVARRO-MANCHON J , Martinez-Dolz L, Almenar Bonet L, Sanchez-Lazaro I, et al
    Predictors of renal dysfunction at 1 year in heart transplant patients.
    Transplantation. 2010;89:977-82.
    PubMed     Text format     Related articles    Abstract available



  39. MCGILLICUDDY JW , Weimert NA, Taber DJ, Turner A, et al
    Can Preemptive Cytomegalovirus Monitoring Be As Effective As Universal Prophylaxis When Implemented As the Standard of Care in Patients at Low Risk?
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  40. MEEHAN AC , Sullivan LC, Mifsud NA, Brooks AG, et al
    Natural killer cell activation in the lung allograft early posttransplantation.
    Transplantation. 2010;89:756-63.
    PubMed     Text format     Related articles    Abstract available



  41. KOTTON CN , Kumar D, Caliendo AM, Asberg A, et al
    International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



  42. PAVLAKIS M , Khwaja K, Mandelbrot D, Tang H, et al
    Renal Allograft Failure Predictors After PAK Transplantation: Results From the New England Collaborative Association of Pancreas Programs.
    Transplantation. 2010.
    PubMed     Text format     Related articles    Abstract available



    February 2010
  43. VAN DER BEEK MT , Berger SP, Vossen AC, van der Blij-de Brouwer CS, et al
    Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.
    Transplantation. 2010;89:320-6.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: